Eculizumab (Soliris®) clinical trials

Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

This study compares five medicines for Neuromyelitis Optica Spectrum Disorder (NMOSD) affecting the eyes and spinal cord. It aims to find which treatment best prevents relapses and has the fewest side effects for adults with NMOSD.